RECENT NEWS
Thermo Fisher Scientific launches scalable Diomni Enterprise software for molecular diagnostics
Thermo Fisher Scientific has introduced Diomni Enterprise software to address challenges with manual molecular testing workflows, with the aim of helping streamline routine diagnostics testing for standardisation and faster results.
Revvity establishes Scientific Centre of Excellence for genomic insight
Global health science solutions company Revvity has announced the establishment of a Scientific Centre of Excellence in Cambridge, UK. Focused on driving genomic insights to accelerate therapeutic discovery, Revvity’s Scientific Centre of Excellence supports the company’s commitment to expanding boundaries in pursuit of a better future for human health.
Cell therapy firm Orgenesis announces name change and additional funding for POC business
Orgenesis, a global biotech company working in cell and gene therapies (CGT) at the point of care, has announced the name change of the POC Services business from Morgenesis to Octomera, effective 30 June 2023, to reflect the growth and focus on providing advanced CGT services, facilities, and technologies.
MHRA’s new Corporate Plan focuses on patient access to innovation
A new Corporate Plan, setting out how the Medicines and Healthcare products Regulatory Agency (MHRA) plans to keep patients safe by enabling access to innovative, safe and effective medical products over the coming three years, has been published.
Microbiology Society responds to Parliamentary Inquiry on COVID-19
The Microbiology Society has welcomed the opportunity from the House of Commons Science and Technology Committee to respond to the inquiry on emerging diseases and lessons learned from COVID-19. The Society consulted with its members that were directly involved in the national response to the pandemic to co-ordinate its response.
NK:IO awarded £1.6 million to develop pioneering NK cell therapy
NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has been awarded £1.6 million in grant funding from Innovate UK’s New Cancer Therapeutics programme.
Mixed-reality training platform for healthcare sector awarded funding
UK immersive technology company FourPlus, along with collaborators Holosphere and the Cell and Gene Therapy Catapult, has been awarded funding from Innovate UK to create and test a mixed-reality training platform that enables customised training delivery for pharmaceutical companies and healthcare.
NHS expands virtual wards to paediatric patients
An expansion of virtual wards will see up to tens of thousands of children able to receive hospital-level care at home, NHS Chief Executive Amanda Pritchard has announced on the 75th anniversary of the NHS.
Novacyt and Yourgene announce merger plans
Diagnostics firm Novacyt has agreed a takeover of Yourgene, a genomic medicine company based in Manchester, in a deal worth £16.7 million.
New £14 million investment targets rare diseases
A new platform will bring together UK strengths in rare diseases research to improve diagnosis and treatment through better understanding of the disease. The UK Rare Disease Research Platform has been established with a £14 million investment over five years by the Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR).
Sphere Fluidics expands Cyto-Mine capabilities
Single cell analysis company Sphere Fluidics has announced updates to its flagship platform, Cyto-Mine, enabling it to be compliant with current Good Manufacturing Practice (cGMP) regulations enforced by the US FDA. By meeting these legally mandated, quality requirements, the company now provides a solution to increase efficiency and productivity of cell line characterisation and selection within drug manufacture workflows.
New online experience from Alpha Laboratories
Alpha Laboratories launched its new website, which has been designed to offer scientists and clinicians easier access to a wealth of information, across its laboratory and diagnostics supplies, services and solutions.
New high-capacity digital hotplates and stirrers from Torrey Pines Scientific
Torrey Pines Scientific has launched its new EchoTherm high capacity hot plates and digital stirring hot plates.
MHRA updates timeframe for CE-marked medical devices
Following the legislation introduced during May to extend the acceptance of CE-marked medical devices on the Great Britain market, the MHRA has further updated its future plans
Biotium introduces labelling kits for IgM antibodies
Biotium has announced the release of its latest product, Mix-n-Stain CF Dye IgM Antibody Labelling Kits. These kits are able to enhance the labelling process for IgM antibodies, enabling researchers to easily obtain high-performance fluorescent IgM conjugates with minimal hands-on time and no purification after labelling.
Register now to visit Lab Innovations 2023
Visitor registration is now open for Lab Innovations, the UK’s largest trade exhibition for the laboratory industry. This year’s show, taking place on 1-2 November, 2023, at the NEC, Birmingham, is set to be the biggest Lab Innovations yet, with the show expanding its floorplan following the success of 2022’s show, which saw the highest attendance rate in the show’s history.
StatLab Medical Products continues expansion
StatLab Medical Products, a leading global developer and manufacturer of medical diagnostic equipment and supplies, is expanding across multiple manufacturing sites to support business growth after successful acquisition of two UK-based histology consumables and diagnostic equipment companies in 2021 and 2022.
NHS Long Term Workforce Plan promises record recruitment and reform to boost patient care
Record numbers of doctors, nurses, dentists and other healthcare staff will be trained in England as part of the first ever Long Term Workforce Plan published by the NHS and backed by the Government.
Honeycomb Biotechnologies and Revvity expand single-cell research
Revvity, in collaboration with single-cell genomics company Honeycomb Biotechnologies, has announced the launch of a suite of new solutions and services that expand the frontiers of single-cell biology: the HIVE CLX Single-Cell RNAseq Solution, BeeNetPLUS analysis workflow.
IBMS Congress – early booking rates ending
If you haven’t already booked your tickets for IBMS Congress, then now is the time as early booking rates end this weekend, on Sunday 2 July.
Latest Issues
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,000 people, with sales and service subsidiaries in eight countries and distributors in more than 90 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei,...
DIA-MHRA Global Summit
Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026
UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026
The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026
UK NEQAS webinar: Epigenetics
Online
1 December, 2026
Weqas Annual POCT Conference 2026
London, Venue - TBC
8-9 December, 2026
UK NEQAS webinar: Fresh Muscle Biopsies
Online
8 December, 2026